Effectiveness of the booster dose of COVID-19 vaccine in the Basque Country during the sixth wave: A nationwide cohort study.

Authors:
Arrospide A; Sagardui MG; Larizgoitia I; Iturralde A; Moreda A and 1 more

Journal:
Vaccine

Publication Year: 2023

DOI:
10.1016/j.vaccine.2023.05.061

PMCID:
PMC10227462

PMID:
37271704

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Vaccine

Abbreviation: Vaccine

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Long-term surveillance of invasive pneumococcal disease: The impact of 10-valent pneumococcal conju…
Reis JN; Azevedo J; de Oliveira AML and 11 more (2024) - Transparency Score: 3/6
Advances in intranasal vaccine delivery: A promising non-invasive route of immunization.
Kehagia E; Papakyriakopoulou P; Valsami G. (2023) - Transparency Score: 2/6
A heterologous AZD1222 priming and BNT162b2 boosting regimen more efficiently elicits neutralizing …
Baek YJ; Kim WJ; Ko JH and 11 more (2023) - Transparency Score: 4/6
A humanized monoclonal antibody targeting protein a promotes opsonophagocytosis of Staphylococcus a…
Bernardino PN; Bhattacharya M; Chen X and 3 more (2023) - Transparency Score: 3/6
Anaphylaxis rates following mRNA COVID-19 vaccination in children and adolescents: Analysis of data…
Maltezou HC; Hatziantoniou S; Theodoridou K and 3 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"appendix a supplementary material the following are the supplementary data to this article: supplementary data 1 data availability data will be made available on request. data availability data will be made available on request. appendix a supplementary data to this article can be found online at https://doi"

Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025